- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | InterCure reports FY results | 1 | Seeking Alpha | ||
| Mi | InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million | 87 | Business Wire | NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) ("InterCure" or the "Company") today announced results for the full year ending December 31, 2023. All amounts... ► Artikel lesen | |
| Mi | Intercure Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| Mi | Intercure Ltd. - 20-F, Annual and transition report of foreign private issuers | 2 | SEC Filings | ||
| 01.04. | InterCure sees annual revenue of NIS 351 million | 2 | Seeking Alpha | ||
| 01.04. | InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million | 326 | Business Wire | NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) ("InterCure" or the "Company") today announced preliminary results for the full year of 2023. All amounts... ► Artikel lesen | |
| 01.04. | Intercure Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 22.03. | InterCure Ltd.: InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint | 305 | Business Wire | InterCure provides an update following recent Cannabis Reform in Germany Expects to launch its first products in Germany in the coming months The Company continues to closely watch... ► Artikel lesen | |
| 14.02. | InterCure advances restoration of Israeli site amid conflict | 1 | Investing.com | ||
| 13.02. | InterCure provides update regarding its Nir Oz facility | 1 | Seeking Alpha | ||
| 13.02. | InterCure Ltd.: InterCure Provides an Update Regarding Nir Oz Facility | 1 | GlobeNewswire (USA) | ||
| 13.02. | Intercure Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 31.01. | InterCure to buy Isreal-based Leon cannabis pharmacy chain | 1 | Seeking Alpha | ||
| 31.01. | InterCure Ltd.: InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain | 194 | GlobeNewswire (Europe) | NEW YORK, and HERZLIYA, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel... ► Artikel lesen | |
| 31.01. | Intercure Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 10.01. | WKEY, INCR and ZJYL are among pre market gainers | 15 | Seeking Alpha | ||
| 14.12.23 | Intercure Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 08.11.23 | Intercure Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 01.09.23 | InterCure Ltd.: InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY | 316 | GlobeNewswire (Europe) | Achieved record revenues of NIS 209 million ($75 million)1 for the first half of 2023 Annualized revenue run rate of NIS 417 million ($149 million) Adjusted EBITDA2 of NIS 30... ► Artikel lesen | |
| 10.07.23 | InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE | 455 | GlobeNewswire (Europe) | NEW YORK and TORONTO and HERZLIYA, Israel, July 10, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the "Company"), announced today that... ► Artikel lesen |
Seite:
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRIA THERAPEUTICS | 8,750 | +1,74 % | Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update | BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today reported... ► Artikel lesen | |
| ROCKET LAB USA | 3,545 | +0,71 % | What's Going On With Rocket Lab Shares Today? | ||
| BOIRON | 34,150 | +0,89 % | BOIRON: Outlook 2023 - Communication calendar 2024 | The Board of Directors of Laboratoires BOIRON met on 19 December 2023, under the chairmanship of Mr Thierry Boiron.
At this meeting, the Board reviewed the latest business and earnings forecasts... ► Artikel lesen | |
| MEDICINOVA | 1,200 | -4,00 % | MediciNova, Inc.: MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO) | LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| ESSA PHARMA | 6,700 | 0,00 % | Essa Pharma Inc. Reports Results Of Annual General Meeting Of Shareholders | SOUTH SAN FRANCISCO, USA and VANCOUVER, CANADA, March 7, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX), a clinical stage pharmaceutical company focused on developing... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 3,365 | +0,15 % | Aquestive stock falls amid Libervant approval, Anaphylm update | ||
| HARROW | 10,410 | 0,00 % | Harrow Health, Inc. Announces Fourth Quarter and Year-End 2023 Financial Results | NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, announced results for the fourth quarter and year ended December 31, 2023. The Company also... ► Artikel lesen | |
| SHINECO | 0,796 | +5,01 % | SHINECO, INC. - 8-K, Current Report | ||
| CYANOTECH | 0,260 | 0,00 % | Delisting of Securities of NanoString Technologies, Inc.; Remark Holdings, Inc.; Sunworks, Inc.; Cyanotech Corporation; Sientra, Inc.; Charge Enterprises, Inc. and others from The Nasdaq Stock Market | NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of NanoString Technologies, Inc. NanoString Technologies, Inc.'s securities... ► Artikel lesen | |
| CUMBERLAND PHARMACEUTICALS | 1,430 | -10,62 % | CUMBERLAND PHARMACEUTICALS INC - 8-K, Current Report | ||
| REVIVA PHARMACEUTICALS | 3,260 | +6,54 % | Reviva Pharmaceuticals: Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia | - FDA acceptance of 4-week global registrational Phase 3 RECOVER-2 study - - Two positive 4-week studies plus a 12-month long-term safety study have potential to support a New Drug Application (NDA)... ► Artikel lesen | |
| IM CANNABIS CORP | 1,160 | 0,00 % | Pre-market Movers: IMCC, CVRX, TGTX, ROOT, PLTN. | WOONSOCKET (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 09.00 A.M. ET).In the Green IM Cannabis Corp. (IMCC) is up over 36% at $0.86.
TG... ► Artikel lesen | |
| LYRA THERAPEUTICS | 5,270 | +2,13 % | Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update | WATERTOWN, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) ("Lyra" or the "Company"), a clinical-stage biotechnology company developing long-acting, anti-inflammatory... ► Artikel lesen | |
| OMNIAB | 4,545 | +2,36 % | OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights | EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and 12 months ended December 31, 2023, and provided operating and partner program... ► Artikel lesen | |
| NEUROGENE | 33,730 | -2,26 % | Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates | NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases... ► Artikel lesen |
Das Unternehmen INTERCURE LTD kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 2,960 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
